CLINICAL_TRIALS
trial_result
· 2022-01-13
Clinical Trial Update: A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer [Phase 3]
Summary
Phase 3 trial evaluating regorafenib in refractory advanced gastro-oesophageal cancer is ongoing or results not reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Australasian Gastro-Intestinal Trials Group | Conditions: Gastro-Oesophageal Cancer | Phase 3 | Status: UNKNOWN